181 related articles for article (PubMed ID: 14605466)
1. Current status of cutaneous T-cell lymphoma: molecular diagnosis, pathogenesis, therapy and future directions.
Dippel E; Klemke CD; Goerdt S
Onkologie; 2003 Oct; 26(5):477-83. PubMed ID: 14605466
[TBL] [Abstract][Full Text] [Related]
2. Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.
Damsky WE; Choi J
Curr Treat Options Oncol; 2016 Jul; 17(7):33. PubMed ID: 27262707
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous T-cell lymphoma: review and current concepts.
Siegel RS; Pandolfino T; Guitart J; Rosen S; Kuzel TM
J Clin Oncol; 2000 Aug; 18(15):2908-25. PubMed ID: 10920140
[TBL] [Abstract][Full Text] [Related]
4. [Malignant lymphoma of the skin].
Burg G; Dommann S; Dummer R
Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of cutaneous T-cell lymphomas].
Rappersberger K; Ortel B; Forstinger C; Wolff K
Wien Klin Wochenschr; 1994; 106(10):300-8. PubMed ID: 8053197
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma.
Litvinov IV; Jones DA; Sasseville D; Kupper TS
Clin Cancer Res; 2010 Apr; 16(7):2106-14. PubMed ID: 20233883
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous T Cell Lymphoma: A Difficult Diagnosis Demystified.
Peterson E; Weed J; Lo Sicco K; Latkowski JA
Dermatol Clin; 2019 Oct; 37(4):455-469. PubMed ID: 31466586
[TBL] [Abstract][Full Text] [Related]
8. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
[TBL] [Abstract][Full Text] [Related]
9. Large-cell transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: molecular and in situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptor.
Wolfe JT; Chooback L; Finn DT; Jaworsky C; Rook AH; Lessin SR
J Clin Oncol; 1995 Jul; 13(7):1751-7. PubMed ID: 7602365
[TBL] [Abstract][Full Text] [Related]
10. Early detection of cutaneous lymphoma.
Abd-el-Baki J; Stefanato CM; Koh HK; Demierre MF; Foss FM
Oncology (Williston Park); 1998 Oct; 12(10):1521-30; discussion 1532-4. PubMed ID: 9798206
[TBL] [Abstract][Full Text] [Related]
11. Analysis of clonality in cutaneous T cell lymphoma and associated diseases.
Wood GS
Ann N Y Acad Sci; 2001 Sep; 941():26-30. PubMed ID: 11594579
[TBL] [Abstract][Full Text] [Related]
12. Erythrodermic CTCL: updated clues to diagnosis and treatment.
Bernengo MG; Quaglino P
G Ital Dermatol Venereol; 2012 Dec; 147(6):533-44. PubMed ID: 23149699
[TBL] [Abstract][Full Text] [Related]
13. Molecular techniques drive cutting edge advancements in management of cutaneous T cell lymphoma.
Lefebvre MN; Borcherding N; Reis RJ; Mou E; Liu V; Jabbari A
Front Immunol; 2023; 14():1228563. PubMed ID: 37654486
[TBL] [Abstract][Full Text] [Related]
14. Molecular biology techniques for the diagnosis of cutaneous T-cell lymphoma.
Wood GS; Haeffner A; Dummer R; Crooks CF
Dermatol Clin; 1994 Apr; 12(2):231-41. PubMed ID: 8045035
[TBL] [Abstract][Full Text] [Related]
15. Controversies in the management of the cutaneous T cell lymphomas.
Zic JA
Dermatol Ther; 2009; 22(5):407-17. PubMed ID: 19845718
[TBL] [Abstract][Full Text] [Related]
16. Analysis of T-cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T-cell lymphoma: a comparison of Southern blot and polymerase chain reaction methods.
Juarez T; Isenhath SN; Polissar NL; Sabath DE; Wood B; Hanke D; Haycox CL; Wood GS; Olerud JE
Arch Dermatol; 2005 Sep; 141(9):1107-13. PubMed ID: 16172307
[TBL] [Abstract][Full Text] [Related]
17. [Management of cutaneous T-cell lymphomas: Recommendations of the French Cutaneous Lymphoma Group].
Beylot-Barry M; Dereure O; Vergier B; Barete S; Laroche L; Machet L; Delfau-Larue MH; D'Incan M; Grange F; Ortonne N; Merlio JP; Bagot M;
Ann Dermatol Venereol; 2010 Oct; 137(10):611-21. PubMed ID: 20932440
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
Paulli M; Berti E
Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
